| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/30/2006 | CN1824189A Medicine and food dual purpose Chinese medicine for preventing and treating blood ejection and its manufacturing method |
| 08/30/2006 | CN1824188A Medicine and food dual purpose Chinese medicine for preventing and treating epistaxis and its manufacturing method |
| 08/30/2006 | CN1824122A Notoginseng supplementing medicinal preparation and its new preparation method |
| 08/30/2006 | CN1824117A Menstruation regulating blood nourishing medicinal preparation and its new preparation method |
| 08/30/2006 | CN1824030A Medicinal formula capable of increasing quantity of leucocyte |
| 08/30/2006 | CN1824022A Blood stanching medicine |
| 08/30/2006 | CN1824018A Dual supplementation preparation of qi and blood and its making method |
| 08/30/2006 | CN1823978A Hemorrhoid blood stopping agent and its preparation method |
| 08/30/2006 | CN1823932A Oral liquid for eliminating dropsy and improving kidney function |
| 08/30/2006 | CN1823862A Chinese medicinal preparation for quickensog blood and transforming stasis, stanching blood and regulating menstruation and its preparation method |
| 08/30/2006 | CN1823857A Preparation technology of sarcandra extract |
| 08/30/2006 | CN1823853A Ginkgodamo drip pill and its preparation method |
| 08/30/2006 | CN1823803A Erigeron breviscapus injection preparation and its preparation method |
| 08/30/2006 | CN1823792A New liver beneficial capsule and its preparation method |
| 08/30/2006 | CN1823780A Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 08/30/2006 | CN1823778A Medicinal composition used for treating cardiovascular cerebrovascular disease and its preparation method |
| 08/30/2006 | CN1823777A Nicergoline soft capsule and its preparation method |
| 08/30/2006 | CN1823746A Compound formula mannitol injection liquid |
| 08/30/2006 | CN1272344C Process for preparing albumin proserum using trans-gene animal |
| 08/30/2006 | CN1272316C Benzamides and related inhibitors of factor Xa |
| 08/30/2006 | CN1272007C Compound formulation for preventing and treating broiler ascites syndrome |
| 08/29/2006 | US7098337 Serotonin receptor agonists such as 6-chloro-4-methyl-1,2,3,4 -tetrahydro-2,4a,5-triaza-fluorene, used for prophylaxis of nervous system, cardiovascular, gastrointestinal, eating or sleep disorders, and as antidiabetic agents |
| 08/29/2006 | US7098318 A carboxy terminal peptide fragment of thrombopoietin is fused with the carboxy terminal of human erythropoietin; highly enhanced in vivo half-life due to increased carbohydrate content; no antigenicity |
| 08/29/2006 | US7098238 2-pyrrolidone derivatives that are photolabile degradation products of bilirubin or biliverdin; used to detect vasospasm or vasoconstriction |
| 08/29/2006 | US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/29/2006 | US7098229 (+)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 08/29/2006 | US7098207 Imidazotriazinones and the use thereof |
| 08/29/2006 | US7098012 DNA demethylase, therapeutic and diagnostic uses thereof |
| 08/29/2006 | US7097985 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 08/29/2006 | US7097823 Administering a RADIONUCLIDE COMPLEXED WITH A CHELATING AGENT SUCH AS MACROCYCLIC AMINOPHOSPHONIC ACID, or tetraazacyclododecanetetramethylenephosphonic acid (DOTMP); osteomyelitis treatment |
| 08/29/2006 | CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 08/29/2006 | CA2373410C A2a receptor agonists |
| 08/29/2006 | CA2247198C Topical pharmaceutical composition containing heparin |
| 08/24/2006 | WO2006089005A2 Combination of selective factor viia and/or xia and plasma kallikrein inhibitors |
| 08/24/2006 | WO2006088944A1 Sphingosine 1- phos phate agonists comprising cycloalkanes and 5 -membered heterocycles substituted by amino and phenyl groups |
| 08/24/2006 | WO2006088011A1 Inhibitor of plasminogen activator inhibitor-1 |
| 08/24/2006 | WO2006087997A1 1-SUBSTITUTED-7-(β-D-GLYCOPYRANOSYLOXY)(AZA)INDOLE COMPOUND AND PHARMACEUTICAL CONTAINING THE SAME |
| 08/24/2006 | WO2006086871A1 Medium-chain length fatty alcohols as stimulators of hematopoiesis |
| 08/24/2006 | WO2006086822A1 A molecule and chimeric molecules thereof |
| 08/24/2006 | WO2006065853A3 Crystalline forms of a factor xa inhibitor |
| 08/24/2006 | WO2006062972A3 Heterocyclic compounds as inhibitors of factor viia |
| 08/24/2006 | US20060191027 Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof |
| 08/24/2006 | US20060189689 Arginine mimetics as factor Xa inhibitors |
| 08/24/2006 | US20060189632 MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine |
| 08/24/2006 | US20060189591 Five-membered heterocyclic derivative |
| 08/24/2006 | US20060189584 Pharmaceutical combinations |
| 08/24/2006 | US20060189531 Thrombopoietic compounds |
| 08/24/2006 | US20060188484 Virus vectors and methods of making and administering the same |
| 08/24/2006 | US20060188483 Virus vectors and methods of making and administering the same |
| 08/24/2006 | US20060188472 HAS-active ingredient conjugates |
| 08/24/2006 | DE60115613T2 Herstellung von rekombinanten muteine des blutgerinnungsfaktors viii in humanen zellinien Production of recombinant muteins of the blood coagulation factor viii in human cell lines |
| 08/24/2006 | CA2597925A1 Use of human hemojuvelin product to regulate hepcidin-mediated iron metabolism |
| 08/24/2006 | CA2597795A1 A molecule and chimeric molecules thereof |
| 08/24/2006 | CA2597269A1 1-substituted-7-(beta-d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 08/24/2006 | CA2596990A1 Sphingosine 1-phosphate agonists comprising cycloalkanes and 5 -membered heterocycles substituted by amino and phenyl groups |
| 08/24/2006 | CA2582262A1 Medium-chain length fatty alcohols as stimulators of hematopoiesis |
| 08/23/2006 | EP1693448A1 Double specific antibodies substituting for functional protein |
| 08/23/2006 | EP1693372A1 Novel Sulfamides and their use as endothelin receptor antagonists |
| 08/23/2006 | EP1693367A1 Piperidine compound and method for producing same |
| 08/23/2006 | EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis |
| 08/23/2006 | EP1692267A2 Methods of organ regeneration |
| 08/23/2006 | EP1691827A1 Use of peptides derived from the alpha or beta chain of human fibronogen for the treatment of shock |
| 08/23/2006 | EP1633346B1 Pyrrolidin-1, 2- dicarboxylic acid- 1- (4- ethinyl- phenyl) - amid|- 2- (phenyl)- amid| derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis |
| 08/23/2006 | EP1485391B1 Phosphate transport inhibitors |
| 08/23/2006 | EP1417205B1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 08/23/2006 | EP1332144B1 Indole derivatives as pde5-inhibitors |
| 08/23/2006 | EP1324981B1 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 08/23/2006 | EP1272457B1 Compounds for modulating cell proliferation |
| 08/23/2006 | EP1237537B1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 08/23/2006 | EP0998916B1 Medicinal compositions for application to mucosa |
| 08/23/2006 | CN1823088A Novel peptides that bind to the erythropoietin receptor |
| 08/23/2006 | CN1820762A Method and device for producing fibrin glue and produced fibrin glue and its medical use |
| 08/23/2006 | CN1820751A Tirofiban powder injection and its preparing method |
| 08/23/2006 | CN1820616A Biological health tea |
| 08/23/2006 | CN1271200C High-biomass iron-riched yeast and breeding method thereof |
| 08/23/2006 | CN1270757C Chinese traditional medicine for treating purpuric disease and method for making the same |
| 08/23/2006 | CN1270716C Freezing-drying powder-injection contg. sodium folinate, and its prepn. method |
| 08/23/2006 | CN1270702C Intravenous injection liquid of coenzyme Q10, and its prepn. method |
| 08/23/2006 | CN1270621C Food-induced antisecretory proteins in egg yolk |
| 08/22/2006 | US7094783 Inhibitors of serine proteases; for therapy of thromboembolic disorder |
| 08/22/2006 | US7094781 Sulfamides and their use as endothelin receptor antagonists |
| 08/22/2006 | US7094776 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease including senile, postmenopausal, and steroid-induced osteoporosis, osteomalacia, renal osteodystrophy and rickets |
| 08/22/2006 | US7094549 mass spectroscopy; medical diagnosis/prognosis; kits |
| 08/17/2006 | WO2006085451A1 Method for reconstruction of blood cell from gene-transferred hematopoietic cell |
| 08/17/2006 | WO2006084683A1 Methods for improving drug disposition |
| 08/17/2006 | US20060183929 Crystals of the sodium salt of pravastatin |
| 08/17/2006 | US20060183770 Sulfonamide derivative having isoxazole ring |
| 08/17/2006 | US20060183742 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 08/17/2006 | US20060183739 Carbonyl compounds |
| 08/17/2006 | US20060183695 Methods of increasing endogenous erythropoietin (EPO) |
| 08/17/2006 | US20060183692 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy |
| 08/17/2006 | US20060183671 Treatment of anemia |
| 08/17/2006 | US20060182814 Biochemically balanced peritoneal dialysis solutions |
| 08/17/2006 | US20060182807 Copolymer and hemoprotein based novel compounds and uses thereof |
| 08/17/2006 | US20060182735 Thrombin preparations and process for their production |
| 08/17/2006 | US20060182733 ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means there for |
| 08/17/2006 | CA2597332A1 Methods for improving drug disposition |
| 08/16/2006 | EP1690936A1 Method of enhancing hematopoiesis-supporting ability of immortalized human bone marrow stroma cell by transferring indian hedgehog gene |
| 08/16/2006 | EP1690857A1 Modified-protein formation inhibitor |
| 08/16/2006 | EP1689424A1 Use of cyclic anabaenopeptin-type peptides for the treatment of a condition wherein inhibition of carboxypeptidase u is beneficial, novel anabaenopeptin derivatives and intermediates thereof |